- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Fierce Pharma Asia-China deals safe from COINS?; Key WCLC data; Legend's new CEO | ||
| 17.09. | FDA approves Ultragenyx's gene therapy Fayuvi for rare neurodegenerative disorder | ||
| 17.09. | Eli Lilly dishes out fresh produce to cultivate Alzheimer's awareness | ||
| 17.09. | Bayer's Kerendia secures FDA nod as first drug in 30 years for Type 1 diabetes-associated kidney disease | ||
| 17.09. | Roche's Lunsumio delivers positive confirmatory trial readout in follicular lymphoma | ||
| 17.09. | Bavarian Nordic secures Sanofi, AstraZeneca vet to fill shoes of longtime CEO Paul Chaplin | ||
| 17.09. | Sun Pharma shines a light on alopecia areata in 'Regrowth Restyled' campaign | ||
| 17.09. | FDA drops warning letter on Bausch & Lomb, citing contamination concerns | ||
| 17.09. | 'People like the sincerity of it': comedian Damon Wayans on humor, relatability and DME awareness in Genentech campaign | ||
| 17.09. | Ex-PHM CEO Andrea Palmer takes top job at Assembled Intelligence | ||
| 16.09. | Vera's strong phase 3 IgAN data for Trutakna intensify kidney disease rivalry | ||
| 16.09. | Cellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts | ||
| 16.09. | Trialynx Wins DPHARM Idol Disrupt 2026 | ||
| 16.09. | BMS, Ono take Amgen to task as FDA's Opdivo biosimilar decision looms | ||
| 16.09. | Reckitt allots $600 million in upgrade of its U.S. operations | ||
| 16.09. | Legend Biotech names Novartis veteran Ingrid Zhang as new CEO | ||
| 16.09. | Ori locks down $120M pact to deploy automated production platform for unnamed, commercial cell therapy | ||
| 15.09. | BioMarin drops Voxzogo development for Noonan syndrome as treatment landscape shifts | ||
| 15.09. | Sanofi strikes Cheplapharm deal to divest 20 older medicines as CEO pushes for innovation | ||
| 15.09. | AbbVie chips in for neurology advocacy through PGA Tour birdie campaign | ||
| 15.09. | Olympic skier Lindsey Vonn joins up with Vertex for pain campaign | ||
| 15.09. | FDA approves first radioligand equivalent, Curium's copycat of Novartis' Lutathera | ||
| 14.09. | Scholar Rock scores long-awaited FDA approval, the first for muscle loss in SMA | ||
| 14.09. | GSK makes 'difficult decision' to shutter German flu vaccine manufacturing site | ||
| 14.09. | Advancing Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.